A Study of AK111 in Subjects With Moderate-to-severe Plaque Psoriasis

Status:
Completed

Trial end date:
2021-03-09

Target enrollment:

Participant gender:

This is a Phase Ib clinical study of multiple dose escalation of AK111 in subjects with moderate-to-severe plaque psoriasis

Phase 1

Akeso